Navigation Links
Retrospective Study Confirms Bovine Carotid Artery Biologic Graft Outperforms Expanded Polytetrafluoroethylene for Hemodialysis Access
Date:4/3/2017

NORTH BRUNSWICK, N.J., April 3, 2017 /PRNewswire/ -- A retrospective review of 120 consecutive hemodialysis grafts placed in 98 patients was evaluated for patency and graft complications. Conducted between 2011 and 2014, the results were published in the March, 2017 Journal of Vascular Surgery, titled "Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access."

Initially presented at the 2015 symposium of the Society of Clinical Vascular Surgery, 52 grafts (43%) were Artegraft® Bovine Carotid Artery Graft™ (BCA) and 68 (57%) were ePTFE grafts from three major manufacturers.

In the review study, primary and primary assisted patencies were similar for BCA and ePTFE grafts. However, secondary patency was higher for BCA, indicating better durability for the biologic graft than for ePTFE grafts in patients whose anatomy precludes placement of an arteriovenous fistula (AVF).

Graft infection, steal and pseudoaneurysm rates were lower for BCA than for ePTFE.  There was a fivefold increase in mortality associated with ePTFE.

The study concluded that BCA is a durable alternative to AVF in contemporary practice.

About Artegraft
Incorporated in 1993, Artegraft Inc. offers surgeons a clinically proven biological alternative to synthetic grafts and an ideal repair and salvage conduit for a fistula.  Artegraft's natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. Artegraft was the first vascular graft approved by the FDA in 1970 and has been in continuous clinical use for over 45 years. For more information, visit www.artegraft.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/retrospective-study-confirms-bovine-carotid-artery-biologic-graft-outperforms-expanded-polytetrafluoroethylene-for-hemodialysis-access-300433713.html


'/>"/>
SOURCE Artegraft
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Retrospective Study Examining Delcaths CHEMOSAT And Isolated Hepatic Perfusion Presented At ECCO Annual Meeting
2. Health 2.0 Unveils "10 Year Global Retrospective"
3. Advocacy Study Highlights Top Locations for High-Growth Companies
4. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
5. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
6. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
7. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
8. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
9. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
10. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
11. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):